Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
资讯
2024-04-25
SHANGHAI, China, April 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedi...